Cargando…
Predicting responses to chemotherapy in the context that matters - the patient
Guided by the belief that the most important setting for understanding tumor response to drugs is the human patient, we developed a technology called CIVO. CIVO enables analysis of up to 8 therapies simultaneously in a patient's tumor, without inducing systemic toxicity and while maintaining th...
Autores principales: | Moreno-Gonzalez, Alicia, Olson, James M., Klinghoffer, Richard A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4845209/ https://www.ncbi.nlm.nih.gov/pubmed/27308571 http://dx.doi.org/10.1080/23723556.2015.1057315 |
Ejemplares similares
-
No time to die: the consensus immunoscore for predicting survival and response to chemotherapy of locally advanced colon cancer patients in a multicenter international study
por: Ascierto, Paolo A., et al.
Publicado: (2020) -
Chemokines and chemokine receptors required for optimal responses to anticancer chemotherapy
por: Ma, Yuting, et al.
Publicado: (2014) -
Subversion of the chemotherapy-induced anticancer immune response by the ecto-ATPase CD39
por: Michaud, Mickaël, et al.
Publicado: (2012) -
Context-dependent utilization of serine in cancer
por: Mehrmohamadi, Mahya, et al.
Publicado: (2015) -
Is preexisting antitumor CD4 T cell response indispensable for the chemotherapy induced immune regression of cancer?
por: Godet, Yann, et al.
Publicado: (2012)